Qube Research & Technologies (QRT)
IMPL

Qube Research & Technologies (QRT)’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IMPL Stock Details IMPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4
Closed -$2 – 4881
2023
Q3 		$2 Buy
+4
New +$4 ﹤0.01% 4026
2022
Q2 		– Sell
-11,867
Closed -$76K – 3270
2022
Q1 		$76K Sell
11,867
-8,475
-42% -$64.1K ﹤0.01% 2118
2021
Q4 		$176K Buy
+20,342
New +$203K ﹤0.01% 2014

Other funds holding IMPL

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IMPL Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of Impel Pharmaceuticals Inc. Common Stock (IMPL) in Q4 2023, closing a stake of 4 shares — an estimated $2 sold.

Qube Research & Technologies (QRT) first reported a position in IMPL in Q4 2021 and held it in 3 quarters. The position peaked at $176K in Q4 2021. 2 funds tracked by Wall St. Rank hold IMPL as of Q4 2023.

  • Qube Research & Technologies (QRT) reported no remaining Impel Pharmaceuticals Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 4 Impel Pharmaceuticals Inc. Common Stock shares in Q4 2023, an estimated $2.
  • Qube Research & Technologies (QRT) first reported a position in Impel Pharmaceuticals Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Impel Pharmaceuticals Inc. Common Stock position peaked at $176K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Impel Pharmaceuticals Inc. Common Stock as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.